Weight-loss party roars, regulator takes punch bowl away
Semaglutide, the key ingredient of Wegovy and Ozempic known for their weight loss properties went off-patent on Friday, triggering a flood of affordably-priced generic variants from Indian manufacturers. However, the DGCI sees cause for concern, and has alerted states and union territories.
Semaglutide, the key ingredient of Wegovy and Ozempic known for their weight loss properties went off-patent on Friday, triggering a flood of affordably-priced generic variants from Indian manufacturers. However, the DGCI sees cause for concern, and has alerted states and union territories.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
